Scientific article

Place des nouveaux antidiabétiques dans la population gériatrique

Published inRevue médicale suisse, vol. 12, no. 521, p. 1101-1106
Publication date2016

Over the last few years, we have noticed the arrival on the market of new antidiabetic treatments. These represent an potential advantage because of the increase in the prevalence of type 2 diabetes, particularly in the elderly population. Nevertheless, elderly patients have a number of frailties that should be considered in the treatment of this condition. There is a lack of literature in this population as elderly are frequently excluded from randomized controlled trials. Therefore, guidelines were developed based on the consensus of experts in geriatrics and diabetology for this specific population. We have to consider the potential benefits and adverse effects of the new antidiabetics in older patients.

  • Aged
  • Diabetes Mellitus, Type 2/drug therapy
  • Frail Elderly
  • Geriatric Assessment
  • Health Status
  • Humans
  • Hypoglycemic Agents/therapeutic use
Citation (ISO format)
BESSE, Sarah, BESSE, Arun, JORNAYVAZ, François. Place des nouveaux antidiabétiques dans la population gériatrique. In: Revue médicale suisse, 2016, vol. 12, n° 521, p. 1101–1106.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation09/13/2017 2:19:00 PM
First validation09/13/2017 2:19:00 PM
Update time03/15/2023 2:02:40 AM
Status update03/15/2023 2:02:39 AM
Last indexation01/17/2024 12:43:57 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack